Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZV6W
|
|||
Former ID |
DIB009021
|
|||
Drug Name |
Albupoietin
|
|||
Synonyms |
Long-acting erythropoietin, HGS; Long-acting erythropoietin, Human Genome Sciences; Long-acting erythropoietin, Teva Pharmaceutical
Click to Show/Hide
|
|||
Indication | Anemia [ICD-11: 3A00-3A9Z; ICD-9: 280-285] | Terminated | [1] | |
Company |
Aventis Behring LLC
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Erythropoietin Receptor (EPOR) | Target Info | Modulator | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
PI3K-Akt signaling pathway | ||||
Jak-STAT signaling pathway | ||||
Hematopoietic cell lineage | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
Pathway Interaction Database | Signaling events mediated by Stem cell factor receptor (c-Kit) | |||
EPO signaling pathway | ||||
WikiPathways | EPO Receptor Signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017518) | |||
REF 2 | Clinical pipeline report, company report or official report of cogenesys. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.